Evidence map›Paper›PMID 37502766›Full record

ArticleJournal of neuroendovascular therapy2021

Results of an International Questionnaire Investigating Changes in Acute Stroke Management between Before and During the COVID-19 Pandemic.

Kyohei Fujita, Shoko Fujii, Hiroto Yamaoka, Fuga Ayabe, Sakyo Hirai, Kittipong Srivatanakul, Kazutaka Sumita

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroendovascular therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kyohei FujitaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Shoko FujiiDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Hiroto YamaokaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Fuga AyabeDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Sakyo HiraiDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Kittipong SrivatanakulDepartment of Neurosurgery, Tokai University, Isehara, Kanagawa, Japan.
Kazutaka SumitaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Tokyo Medical and Dental University · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The present study investigated changes in the management of acute stroke patients between before and during the coronavirus disease 2019 (COVID-19) pandemic in several countries using a questionnaire. Methods: A questionnaire survey was conducted at 23 stroke centers in 20 countries to examine how stroke management systems have changed from 2019 (before the COVID-19 pandemic) to 2020 (during the COVID-19 pandemic). Results: Questionnaire responses were obtained from 14 stroke centers (61%) in 14 countries. Among the surveyed stroke centers, 36% utilized full personal protective equipment (PPE) including N95 masks in all cases. After the proper application of infection precautions and screening for COVID-19, the initial imaging modality and indications for endovascular thrombectomy (ET) for ischemic stroke remained unchanged in more than 85% of the surveyed stroke centers. The transmission of COVID-19 from stroke patients to doctors or nurses was confirmed in 29% of the surveyed stroke centers, and hospital-acquired infection from patients to other patients occurred in 25%. The number of cases undergoing ET decreased by 10-70% in 50% of stroke centers during the COVID-19 pandemic. Despite successful recanalization, 50% of patients who underwent ET died, and death was mainly attributed to COVID-19-related systemic complications. Conclusion: No significant differences were observed in stroke management or treatment strategies between before and during the COVID-19 pandemic in most stroke centers, except for COVID-19 precautions. However, the higher proportion of hospital-acquired infections and increased morbidity rate among patients despite successful recanalization due to COVID-19-related systemic complications are important findings.

Indexed as

coronavirus disease 2019strokethrombectomy

Identifiers

PMID37502766
PMCPMC10370581
OpenAlexW3178237634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.